Loading...

World-Class Retina Care. Community-Based Caring.
Posted On October 18, 2023 / By / Posted in Blog

New Treatment for Wet AMD and Diabetic Eye Disease Reduces Treatment Burden for Patients by Extending Dosing Intervals

On August 18, 2023, the U.S. Food and Drug Administration (FDA) approved Eylea HD (aflibercept), a high-dose version of Eylea, for the treatment of several retinal conditions, including advanced neovascular age-related macular

read more
Posted On / By / Posted in Blog

New Treatments Available for Geographic Atrophy

We know geographic atrophy (GA) can negatively impact patients’ quality of life and independence. While it still cannot be cured, Texas Retina is excited to finally have two new GA treatment options

read more
Posted On October 12, 2023 / By / Posted in Blog

Getting to Know Diana Laura, MD

Board-certified ophthalmologist and retina specialist Diana M. Laura, MD, joined Texas Retina Associates in September 2022, and cares for patients in our Dallas Main, Rockwall and Wichita Falls offices. She completed her

read more
Posted On October 11, 2023 / By / Posted in Blog

Dr. Abbey Publishes Case Report on Macular Hole Closure with Intravitreal Dexamethasone Implant

In the September 2023 issue of the peer-reviewed medical journal Ophthalmic Surgery, Lasers and Imaging Retina, Texas Retina’s Ashkan Abbey, MD, describes the use of a dexamethasone intravitreal implant to close a

read more
Posted On October 2, 2023 / By / Posted in Blog

New Clinical Trials Available at Texas Retina

Our physicians remain committed to participating in ongoing retina research, providing our patients with access to promising new treatments through clinical trials. In fact, our research program has grown to become one

read more
Posted On September 26, 2023 / By / Posted in Blog

Dr. Abbey Publishes Research on Effectiveness of a Long-acting Injectable Steroid for Patients with Cystoid Macular Edema After Vitrectomy

Long-acting injectable steroids have emerged as a new way to treat chronic intraocular inflammation and cystoid macular edema (CME) that reduces the treatment frequency and burden for retina patients. Texas Retina’s Ashkan

read more
Posted On September 18, 2023 / By / Posted in Blog

Inflammatory Eye Disease Awareness Week

Prevent Blindness has declared September 18 – 24, 2023, as Inflammatory Eye Disease Awareness Week.  There are a number of inflammatory eye conditions. The one we specialize in at Texas Retina Associates

read more
Posted On August 18, 2023 / By / Posted in Blog

Check Out Our New Patient Education Videos!

We know that anything affecting your sight can be scary, and at Texas Retina, we have always believed in treating our patients as we would our own families. That means not only

read more
Posted On August 11, 2023 / By / Posted in Blog

Texas Retina’s New Waco Office Wins Outstanding Construction Award

The Associated General Contractors of America Texas Building Branch (AGCTBB) recently announced that they are awarding their annual “Healthcare 1 Outstanding Construction Award” to Mazanec Construction Company and Texas Retina’s new Waco

read more
Posted On August 8, 2023 / By / Posted in Blog

Dr. Abbey Presented at the American Society of Retina Specialists 2023 Annual Meeting

Texas Retina Associates’ Ashkan M. Abbey, MD, recently presented at the 41st Annual Scientific Meeting of the American Society of Retina Specialists (ASRS) held in Seattle. ASRS is the largest organization of

read more